Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in multiple countries, including in the United States, in Argentina, and in Brazil. It is testing brenipatide for Bipolarity.
This study is recruiting in South Korea. It is testing olanzapine for Bipolarity.
This study is completed in the United States. It is testing spoken Language for Bipolarity.
This study is recruiting in Italy. It focuses on Bipolarity.
This observational study is following people with psychosis or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is recruiting in the United States. It is testing adverse Events and Change for Bipolarity.
This study is recruiting in the United States and in Russian Federation. It is testing change for depression.
This study is recruiting in multiple countries, including in the United States, in Argentina, and in Australia. It is testing KarXT for manic episodes in bipolarity type I.
This study is recruiting in the United States. It focuses on adults with tardive dyskinesia who remain symptomatic while receiving or after stopping a VMAT2 inhibitor.
This study is recruiting in multiple countries, including in the United States, in Argentina, and in Bulgaria. It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.
This study is recruiting in multiple countries, including in the United States, in Argentina, and in Australia. It is testing KarXT for manic episodes in bipolarity type I.
This study is recruiting in multiple countries, including in the United States, in Croatia, and in India. It is testing KarXT for manic episodes in bipolarity type I.
This study has public registry information in China. It is testing Efficacy of VR for Bipolarity.
This study is looking at whether psychoeducation can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with bipolarity I or II With a Major Depressive Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with bipolarity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at care and outcomes for people with Bipolarity II, Most Recent Episode Major Depressive, Current Depressive Episode, or Treatment Resistant Depression. Some participants may receive Sham aiTBS instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether questionnaires and follow-up can help people with Bipolarity II, Depression in bipolarity, or Suicidality. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Schizophrenia, bipolarity, major depression, or Stress Disorder, Post-Traumatic. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with bipolarity, Alcohol Drinking, or Alcohol Use Disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) with placebo for people with Treatment-resistant Depression in bipolarity. Participants receive Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) or placebo and complete study visits and assessments.
This study is looking at whether Bright light therapy can help people with Depression in bipolarity. Participants take part in Bright light therapy and complete follow-up assessments.
This study is looking at care and outcomes for people with Bipolarity I or Mania. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with depression or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.